Canon C, Augier C, Reizenstein P, Goutner A, de Vassal F, Mathé G
Biomed Pharmacother. 1983;37(2):90-2.
Fourteen out of 21 non-Hodgkin lymphoma (NHL) and 3/11 chronic lymphoid leukemia cells (CLL) had the common acute lymphoid leukemia antigen (CALLA) All 32 patients had monoclonal B-cell proliferation. The CLL patients had 90% CALLA positive cells while the proportion of their leukemic elements was superior. Lymph-nodes or bone marrow invaded by a B monoclonal tumor cell population of NHL had significantly more CALLA positive cells (42.1 +/- 32.5%) than non-invaded tissues (11.4 +/- 10.3%). In NHL tissues with monoclonal B-cells, lymph-nodes had significantly more CALLA positive cells (56.0 +/- 29.9%) than marrow (23.5 +/- 27.7%). It is well known that the (CALLA) is not specific for ALL. It has been believed to be a differentiation antigen on pre B-cells. The present study confirms that it also occurs on B-cells (2,4,6,7,8,9,10,11).
21例非霍奇金淋巴瘤(NHL)中有14例,11例慢性淋巴细胞白血病(CLL)中有3例,其细胞具有常见的急性淋巴细胞白血病抗原(CALLA)。所有32例患者均有单克隆B细胞增殖。CLL患者有90%的CALLA阳性细胞,而其白血病细胞成分的比例更高。NHL的B单克隆肿瘤细胞群体侵犯的淋巴结或骨髓中,CALLA阳性细胞(42.1±32.5%)明显多于未受侵犯的组织(11.4±10.3%)。在有单克隆B细胞的NHL组织中,淋巴结的CALLA阳性细胞(56.0±29.9%)明显多于骨髓(23.5±27.7%)。众所周知,(CALLA)并非ALL所特有。它一直被认为是前B细胞上的一种分化抗原。本研究证实它也存在于B细胞上(2,4,6,7,8,9,10,11)。